Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDHI R132 mutation effects in human glioblastoma

Nadia A. Atai, Nynke A. Renkema-Mills, Joost Bosman, Nadja Schmidt, Denise Rijkeboer, Wikky Tigchelaar, Klazien S. Bosch, Dirk Troost, Ard Jonker, Fonnet E. Bleeker, Hrvoje Miletic, Rolf Bjerkvig, Philip C. de Witt Hamer, Cornelis J.F. van Noorden

Research output: Contribution to journalArticleResearchpeer-review

26 Citations (Scopus)

Abstract

The somatic IDH1 R132 mutation in the isocitrate dehydrogenase 1 gene occurs in high frequency in glioma and in lower frequency in acute myeloid leukemia and thyroid cancer but not in other types of cancer. The mutation causes reduced NADPH production capacity in glioblastoma by 40% and is associated with prolonged patient survival. NADPH is a major reducing compound in cells that is essential for detoxification and may be involved in resistance of glioblastoma to treatment. IDH has never been considered important in NADPH production. Therefore, the authors investigated NADPHproducing dehydrogenases using in silico analysis of human cancer gene expression microarray data sets and metabolic mapping of human and rodent tissues to determine the role of IDH in total NADPH production. Expression of most NADPH-producing dehydrogenase genes was not elevated in 34 cancer data sets except for IDH1 in glioma and thyroid cancer, indicating an association with the IDH1 mutation. IDH activity was the main provider of NADPH in human normal brain and glioblastoma, but its role was modest in NADPH production in rodent brain and other tissues. It is concluded that rodents are a poor model to study consequences of the IDH1 R132 mutation in glioblastoma.

Original languageEnglish
Pages (from-to)489-503
Number of pages15
JournalJournal of Histochemistry and Cytochemistry
Volume59
Issue number5
DOIs
Publication statusPublished - 2011
Externally publishedYes

Keywords

  • G6PDH
  • Glioblastoma
  • IDH1
  • In silico analysis
  • Metabolic mapping
  • Mutation
  • NADPH
  • dehydrogenase

Fingerprint

Dive into the research topics of 'Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDHI R132 mutation effects in human glioblastoma'. Together they form a unique fingerprint.

Cite this